SUPERIORITY OF SEQUENTIAL METHOTREXATE, FLUOROURACIL, AND LEUCOVORIN TO FLUOROURACIL ALONE IN ADVANCED SYMPTOMATIC COLORECTAL-CARCINOMA - A RANDOMIZED TRIAL
- 1 October 1989
- Vol. 7 (10) , 1437-1446
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Chemotherapy of Advanced Colorectal Cancer A Randomized Trial of Sequential Methotrexate and 5-FluorouracilAmerican Journal of Clinical Oncology, 1987
- Sequential methotrexate-5-FU-leucovorin (MFL) in advanced colorectal cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- Chemotherapy of large bowel carcinoma—fluorouracil (FU) + hydroxyurea (HU) vs. methyl-CCNU, oncovin, fluorouracil, and streptozotocin (MOF-Strep)American Journal of Clinical Oncology, 1985
- Prognostic factors in advanced colorectal carcinomaThe American Journal of Medicine, 1983
- MODULATION OF 5-FLUOROURACIL METABOLISM AND CYTO-TOXICITY BY ANTI-METABOLITE PRETREATMENT IN HUMAN COLORECTAL ADENOCARCINOMA HCT-81981
- Survival and response to chemotherapy for advanced colorectal adenocarcinoma. An eastern cooperative oncology group reportCancer, 1980
- Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil vincristine and streptozotocin (MOF-strep)Cancer, 1980
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU.A southwest oncology group studyCancer, 1976